The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company made one thing clear for Xiayang Qiu, a structural chemist and biotechno ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

A newly published study has highlighted how artificial intelligence and robotics-driven computational methods are ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

Their project, called Phytogene, harnesses the power of “biopharming” — a method that transforms plants into living drug ...

Ricky Mulvey: Speaking of the design ... on pills for weight loss, but they mean really different things by them. It makes a big difference whether you mean, I'm taking a peptide and making ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Though it could have lots of use cases in the future, Phytogene's first order of business is synthesizing glucagon-like peptide-1 (GLP ... to help patients lose weight and lower their blood ...

is part of a class of medications called glucagon-like peptide 1 (GLP-1) agonists. In 2023, the Food and Drug Administration approved it for weight loss in adults with a body mass index over 30 or ...

BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs ...